These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 17721661)

  • 1. Metastasizing squamous cell carcinomas in a patient treated with extracorporeal photopheresis for cutaneous T-cell lymphoma.
    Hoetzenecker W; Benedix F; Woelbing F; Yazdi A; Breuninger H; Röcken M; Berneburg M
    Acta Derm Venereol; 2007; 87(5):445-6. PubMed ID: 17721661
    [No Abstract]   [Full Text] [Related]  

  • 2. Aggressive squamous cell carcinomas in patients treated with extracorporeal photopheresis for cutaneous T-cell lymphoma.
    Nehal KS; Green KB; Lim HW
    Arch Dermatol; 1995 Oct; 131(10):1211-2. PubMed ID: 7574848
    [No Abstract]   [Full Text] [Related]  

  • 3. Invasive squamous cell carcinoma with sporotrichoid metastasis in a patient with cutaneous T cell lymphoma treated with chronic extracorporeal photopheresis.
    Gmyrek R; Beer R; Elizeri Y; Oster MW; Silvers DN; Schneiderman P; Grossman ME
    Cutis; 1999 Oct; 64(4):261-4. PubMed ID: 10544882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photopheresis for the treatment of cutaneous T-cell lymphoma.
    Lim HW; Edelson RL
    Hematol Oncol Clin North Am; 1995 Oct; 9(5):1117-26. PubMed ID: 8522488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.
    Scarisbrick JJ; Taylor P; Holtick U; Makar Y; Douglas K; Berlin G; Juvonen E; Marshall S;
    Br J Dermatol; 2008 Apr; 158(4):659-78. PubMed ID: 18241274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Extracorporeal photopheresis--a new therapeutic concept].
    Trattner A; David M
    Harefuah; 1993 Nov; 125(10):368-70. PubMed ID: 8253407
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythrodermic cutaneous T cell lymphoma with hypereosinophilic syndrome: Treatment with interferon alfa and extracorporeal photopheresis.
    Lee CH; Mamelak AJ; Vonderheid EC
    Int J Dermatol; 2007 Nov; 46(11):1198-204. PubMed ID: 17988344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Documented effect of extra corporeal photopheresis on T-cell mediated diseases].
    Kofoed K; Schiødt I; Gniadecki R
    Ugeskr Laeger; 2011 Jun; 173(26):1869-74. PubMed ID: 21712008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosage guidelines: extracorporeal photochemotherapy (photopheresis).
    Heald PW; Perez MI; Gasparro FP
    Arch Dermatol; 1990 Oct; 126(10):1369. PubMed ID: 2221948
    [No Abstract]   [Full Text] [Related]  

  • 10. Photopheresis in the treatment of cutaneous T-cell lymphoma: current status.
    Zic JA
    Curr Opin Oncol; 2012 Jan; 24 Suppl 1():S1-10. PubMed ID: 22157241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-scale extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma: a report of 3 cases.
    Schreiner T; Gaczkowski A; Scharffetter-Kochanek K; Borberg H
    Transfus Apher Sci; 2005 Apr; 32(2):197-203. PubMed ID: 15784454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group.
    McKenna KE; Whittaker S; Rhodes LE; Taylor P; Lloyd J; Ibbotson S; Russell-Jones R; ;
    Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photopheresis therapy of cutaneous T-cell lymphoma: the Yale-New Haven Hospital experience.
    Heald PW; Perez MI; Christensen I; Dobbs N; McKiernan G; Edelson R
    Yale J Biol Med; 1989; 62(6):629-38. PubMed ID: 2534648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extracorporeal photopheresis in dermatology].
    Pérez-Carmona L; Harto-Castaño A; Díez-Recio E; Jaén-Olasolo P
    Actas Dermosifiliogr; 2009; 100(6):459-71. PubMed ID: 19709550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic applications of photopheresis.
    Rook AH; Cohen JH; Lessin SR; Vowels BR
    Dermatol Clin; 1993 Apr; 11(2):339-47. PubMed ID: 8477547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal photochemotherapy in the early treatment of cutaneous T-cell lymphoma.
    Fimiani M; Rubegni P; D'Ascenzo G; Andreassi L
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):828-30. PubMed ID: 7929941
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of poikiloderma vasculare atrophicans, a rare variant of cutaneous T-cell lymphoma, responding to extracorporeal photopheresis.
    Kreuter A; Hoffmamm K; Altmeyer P
    J Am Acad Dermatol; 2005 Apr; 52(4):706-8. PubMed ID: 15793532
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety of a new, single, integrated, closed photopheresis system in patients with cutaneous T-cell lymphoma.
    Bisaccia E; Vonderheid EC; Geskin L
    Br J Dermatol; 2009 Jul; 161(1):167-9. PubMed ID: 19298276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring HRQOL in patients with cutaneous T-cell lymphoma undergoing therapy with oral bexarotene and extracorporeal photopheresis.
    Demierre MF; Ferzli P; Miller D
    Arch Dermatol; 2007 May; 143(5):659-61. PubMed ID: 17515522
    [No Abstract]   [Full Text] [Related]  

  • 20. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma.
    Duvic M; Chiao N; Talpur R
    J Cutan Med Surg; 2003; 7(4 Suppl):3-7. PubMed ID: 12958700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.